Guido Dalbagni
- Urology top 0.02%
- Urological Disorders and Treatments 66
- Surgery top 0.05%
- Bladder and Urothelial Cancer Treatments 234
- Urinary and Genital Oncology Studies 155
- Esophageal Cancer Research and Treatment 17
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment 24
- Prostate Cancer Diagnosis and Treatment 12
- Cancer Research top 2%
-
- Epigenetics and DNA Methylation 21
-
- Cancer Research and Treatments 14
- Co-authors
- Harry W. HerrBernard H. BochnerS. Machele DonatVictor E. ReuterZuo‐Feng ZhangCarlos Cordon‐CardoShahrokh F. ShariatAndrew J. Vickers
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)Journal of Clinical Oncology (29 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Guido Dalbagni
265 papers receiving 14.9k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Urology 4.8k
- Surgery 12.7k
- Oncology 3.1k
- Pulmonary and Respiratory Medicine 2.6k
- Cancer Research 1.0k
Countries citing papers authored by Guido Dalbagni
This map shows the geographic impact of Guido Dalbagni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Dalbagni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Dalbagni more than expected).
Fields of papers citing papers by Guido Dalbagni
This network shows the impact of papers produced by Guido Dalbagni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Dalbagni. The network helps show where Guido Dalbagni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guido Dalbagni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 21 | |
| 3 | 2021 | 33 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 28 | |
| 6 | 2019 | 15 | |
| 7 | 2018 | 32 | |
| 8 | 2017 | 17 | |
| 9 | 2016 | 22 | |
| 10 | 2013 | 30 | |
| 11 | Epidemiology and Risk Factors of Urothelial Bladder Cancerbreakdown → | 2012 | 1526 |
| 12 | 2012 | 52 | |
| 13 | 2009 | 27 | |
| 14 | Comparison of bladder cancer survival among Japanese, Chinese, Filipino, Hawaiian and Caucasian populations in the United States. | 2003 | 13 |
| 15 | 2003 | 29 | |
| 16 | 2000 | 57 | |
| 17 | 1996 | 32 | |
| 18 | 1994 | 2 | |
| 19 | 1993 | 437 | |
| 20 | 1992 | 6 |
About Guido Dalbagni
Guido Dalbagni is a scholar working on Urology, Surgery and Oncology, having authored 276 papers that have together received 15.3k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (234 papers), Urinary and Genital Oncology Studies (155 papers), Urological Disorders and Treatments (66 papers), Renal cell carcinoma treatment (24 papers), Epigenetics and DNA Methylation (21 papers), Esophageal Cancer Research and Treatment (17 papers), Cancer Research and Treatments (14 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). The work is most often cited by research in Urology (4.8k citations), Surgery (12.7k citations) and Oncology (3.1k citations). Guido Dalbagni has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Harry W. Herr, Bernard H. Bochner, S. Machele Donat, Victor E. Reuter, Zuo‐Feng Zhang, Carlos Cordon‐Cardo, Shahrokh F. Shariat, Andrew J. Vickers, Paul Russo and Dean F. Bajorin. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.